Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Venture Capital Funds Creep Back Up For Device Firms

This article was originally published in The Gray Sheet

Executive Summary

Venture capital investment in device firms grew 14% in the fourth quarter of 2009 compared to a weak year-ago quarter, reflecting an increase in VC funding of very early stage entities and an upswing in private placements to diagnostics and non-implantable device makers

You may also be interested in...



National Science Foundation Funding A Solid Option For Start-Ups - Insera

Stroke treatment developer Insera applied for a $150,000 National Science Foundation grant in 2009 after concluding that more traditional capital sources remained out of reach amid the economic downturn. The funding route stands as a good model for other device start-ups as well, Insera says

National Science Foundation Funding A Solid Option For Start-Ups - Insera

Stroke treatment developer Insera applied for a $150,000 National Science Foundation grant in 2009 after concluding that more traditional capital sources remained out of reach amid the economic downturn. The funding route stands as a good model for other device start-ups as well, Insera says

VCs Warn New Device Tax Could Reduce Investments

Venture capitalists see the new medical device industry tax under health care reform as adding to mounting pressures on smaller start-ups that could lead to smaller VC investments

Related Content

Topics

UsernamePublicRestriction

Register

MT028538

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel